Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan

Tsunakuni Ikka, Misao Fujita, Taichi Hatta, Tetsu Isobe, Kenji Konomi, Tatsuo Onishi, Shoji Sanada, Yuichiro Sato, Shimon Tashiro, Morikuni Tobita

Research output: Contribution to journalShort surveypeer-review

1 Citation (Scopus)

Abstract

We outlined five studies regarding the quality of the review by committees based on the Act on the Safety of Regenerative Medicine. The findings raise serious concerns about the independence, integrity, and quality of reviews of therapeutic plans by these committees with inappropriately close relationships to medical institutions and companies.

Original languageEnglish
Pages (from-to)613-617
Number of pages5
JournalStem cell reports
Volume18
Issue number3
DOIs
Publication statusPublished - 2023 Mar 14

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Developmental Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan'. Together they form a unique fingerprint.

Cite this